Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2008-07-01
2008-07-01
Campell, Bruce (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S091500
Reexamination Certificate
active
11440177
ABSTRACT:
Novel methods of regulating cellular apoptosis by affecting the interaction of hepatitis B X-interacting protein (HBXIP) with Survivin are described. More specifically, these novel methods of enhancing apoptosis of neoplastic cells comprises inhibiting interaction of hepatitis B X-interacting protein (HBXIP) with Survivin.
REFERENCES:
patent: 2002/0173026 (2002-11-01), Wettstein et al.
Ambrosini, G. et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med 3:917-921 (1997).
Banks, DP et al. Survivin does not inhibit caspase-3 activity. Blood 96:4002-4003 (2000).
Bratton, SB et al. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J 20:998-1009 (2001).
Cryns, V et al. Proteases to die for. Genes Dev. 12:1551-1570 (1998).
Deveraux, QL et al. IAP family proteins: Suppressors of apoptosis. Genes Dev. 13:239-252 (1999).
Deveraux, QL et al. X-linked IAP is a direct inhibitor of cell death proteases. Nature 388:300-304 (1997).
Gottlob, K. et al. The Hepatitis B virus HBx protein inhibits caspase-3 activity. J Biol Chem 273:33347-33353 (1998).
Grossman, D. et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 108:991-999 (2001).
Kim, CM. et al. HBx gene of Hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320 (1991).
Li, F. et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584 (1998).
Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/Capsase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489 (1997).
Lok, AS. Hepatitis B infection: Pathogenesis and management. J Hepatol 32:89-97 (2000).
Marusawa, H. et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. The EMBO J. 222:2729-2740 (2003).
Matsuzawa, S. et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Heptatology 31:488-495.
Melegari, M. et al. Cloning and characterization of novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 72:1737-1743 (1998).
Murakami, S. Hepatitis B virus X protein: A multifunctional viral regulator. J Gastroenterol 36:651-660 (2001).
O'Connor, DS et al. Regulation of apoptosis at cell division bycdc2phosphorylation of survivin PNAS USA 97:13103-13107 (2000).
Reed, JC et al. BIRinging chromosomes through cell division—and survivin the experience. Cell 102:545-548 (2000).
Reed, JC. The survivin saga goes in vivo. J Clin invest 108:965-969 (2001).
Riedl, SJ et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104:791-800 (2001).
Salvesen, GS. Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 9:3-5 (2002).
Shin, S et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochem 40:1117-1123 (2001).
Stennicke, HR et al. Caspase-9 can be activated without proteolytic processing. J Biol Chem 274:8359-8362 (1999).
Sun, C et al. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 401:818-822 (1999).
Tamm, I et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320 (1998).
Velculescu, VE et al. Analysis of human transcriptomes. Nature Gen 23:387-388 (1999).
Verdecia, MA et al. Structure of the Human anti-apoptotic protein survivin reveals dimeric arrangement. Nature Struct Biol 7:602-608 (2000).
Yagihashi et al. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem. 2001. 47(9):1729-1731.
Yang, J et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132 (1997).
Zhou, Q et al. Targeted protease specificity of the viral serpin CrmA: analysis of five caspases. J Biol Chem 272:7797-7800 (1997).
Zou, H et al. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549-1156 (1999).
Reed John C.
Tamm Ingo
Boesen Agnieszka
Burnham Institute for Medical Research
Campell Bruce
Needle & Rosenberg PC
LandOfFree
Use of hepatitis B X-interacting protein (HBXIP) in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hepatitis B X-interacting protein (HBXIP) in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hepatitis B X-interacting protein (HBXIP) in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3937525